140 related articles for article (PubMed ID: 23748833)
21. Histopathology predicts clinical outcome in advanced epithelial ovarian cancer patients treated with neoadjuvant chemotherapy and debulking surgery.
Muraji M; Sudo T; Iwasaki S; Ueno S; Wakahashi S; Yamaguchi S; Fujiwara K; Nishimura R
Gynecol Oncol; 2013 Dec; 131(3):531-4. PubMed ID: 24096109
[TBL] [Abstract][Full Text] [Related]
22. Synchronous occurrence of advanced adenocarcinoma with a stromal tumor in the stomach: a case report.
Salemis NS; Gourgiotis S; Tsiambas E; Karameris A; Tsohataridis E
J Gastrointestin Liver Dis; 2008 Jun; 17(2):213-5. PubMed ID: 18568146
[TBL] [Abstract][Full Text] [Related]
23. Laparoscopic resection of sporadic synchronous gastric and jejunal gastrointestinal stromal tumors: report of a case.
Dell'Avanzato R; Carboni F; Palmieri MB; Palmirotta R; Guadagni F; Pippa G; Santeusanio G; Antimi M; Lopez M; Carlini M
Surg Today; 2009; 39(4):335-9. PubMed ID: 19319643
[TBL] [Abstract][Full Text] [Related]
24. A case of ovarian cancer associated with hypercalcemia.
Sawada M; Uehara T
Jpn J Clin Oncol; 2008 Oct; 38(10):719. PubMed ID: 18845526
[No Abstract] [Full Text] [Related]
25. Neoadjuvant chemotherapy followed by interval cytoreductive surgery in patients with unresectable, advanced stage epithelial ovarian cancer: a single centre experience.
Bilici A; Salepci T; Dane F; Gumus M; Ustaalioglu BB; Seker M; Salman T; Turan C; Unal O; Yaylaci M
Arch Gynecol Obstet; 2010 Oct; 282(4):417-25. PubMed ID: 20035339
[TBL] [Abstract][Full Text] [Related]
26. Outcomes of advanced epithelial ovarian cancer treated with neoadjuvant chemotherapy.
Maheshwari A; Kumar N; Gupta S; Rekhi B; Shylasree TS; Dusane R; Bajpai J; Ghosh J; Gulia S; Deodhar K; Menon S; Popat P; Sable N; Thakur M; Kerkar R
Indian J Cancer; 2018; 55(1):50-54. PubMed ID: 30147093
[TBL] [Abstract][Full Text] [Related]
27. Impact of bevacizumab containing first line chemotherapy on recurrent disease in epithelial ovarian cancer: A case-control study.
Petrillo M; Amadio G; Salutari V; Paris I; Di Stefano MG; Ferandina G; Scambia G; Fagotti A
Gynecol Oncol; 2016 Aug; 142(2):231-6. PubMed ID: 27215633
[TBL] [Abstract][Full Text] [Related]
28. Multiple gastrointestinal stromal tumors of the ileum and neurofibromatosis type 1.
Beltran MA; Cruces KS; Barría C; Verdugo G
J Gastrointest Surg; 2006 Feb; 10(2):297-301. PubMed ID: 16455465
[TBL] [Abstract][Full Text] [Related]
29. Prognostic evaluation of tumour type and other histopathological characteristics in advanced epithelial ovarian cancer, treated with surgery and paclitaxel/carboplatin chemotherapy: cell type is the most useful prognostic factor.
Bamias A; Sotiropoulou M; Zagouri F; Trachana P; Sakellariou K; Kostouros E; Kakoyianni K; Rodolakis A; Vlahos G; Haidopoulos D; Thomakos N; Antsaklis A; Dimopoulos MA
Eur J Cancer; 2012 Jul; 48(10):1476-83. PubMed ID: 22047635
[TBL] [Abstract][Full Text] [Related]
30. Ovarian large cell neuroendocrine carcinoma in the youngest woman.
Kwon YS; Im KS; Choi DI
Eur J Gynaecol Oncol; 2016; 37(2):244-6. PubMed ID: 27172753
[TBL] [Abstract][Full Text] [Related]
31. Gastrointestinal stromal tumor of the stomach with rhabdoid phenotype: immunohistochemical, ultrastructural, and immunoelectron microscopic evaluation.
Richmond JA; Mount SL; Schwarz JE
Ultrastruct Pathol; 2004; 28(3):165-70. PubMed ID: 15471430
[TBL] [Abstract][Full Text] [Related]
32. [Potential value of CA125 kinetic monitoring in the initial management of advanced epithelial ovarian cancer].
Vignot S; Brochet C; Debord C; Lauratet B; Bernard M
Ann Biol Clin (Paris); 2011; 69(5):597-604. PubMed ID: 22008142
[TBL] [Abstract][Full Text] [Related]
33. Leiomyosarcoma with synchronous clear cell ovarian carcinoma.
Rettenmaier M; Epstein HD; Abaid LN; Bechtol KA; Goldstein BH
Onkologie; 2010; 33(12):695-7. PubMed ID: 21124041
[TBL] [Abstract][Full Text] [Related]
34. Perioperative and clinical outcomes in the management of epithelial ovarian cancer using a robotic or abdominal approach.
Feuer GA; Lakhi N; Barker J; Salmieri S; Burrell M
Gynecol Oncol; 2013 Dec; 131(3):520-4. PubMed ID: 24080421
[TBL] [Abstract][Full Text] [Related]
35. The role of serum CA-125 levels and CA-125 tissue expression positivity in the prediction of the recurrence of stage III and IV epithelial ovarian tumors (CA-125 levels and tissue CA-125 in ovarian tumors).
Gundogdu F; Soylu F; Erkan L; Tatli O; Mavi S; Yavuzcan A
Arch Gynecol Obstet; 2011 Jun; 283(6):1397-402. PubMed ID: 20645105
[TBL] [Abstract][Full Text] [Related]
36. [Epithelial ovarian cancer].
Hilpert F; Krause G; Venhoff L; Kühnle E; Schem C; Maass N
Ther Umsch; 2007 Jul; 64(7):375-80. PubMed ID: 17948754
[TBL] [Abstract][Full Text] [Related]
37. [Pancreatic neuroendocrine tumour - laparoscopic distal pancreatectomy with splenectomy and partial gastric resection].
Mittermair R
Zentralbl Chir; 2013 Dec; 138(6):593-5. PubMed ID: 24399463
[TBL] [Abstract][Full Text] [Related]
38. [Young female multiple gastric GIST presenting with lymph node metastasis: Sporadic or incomplete Carney's triad?].
Noomene R; Mchirgui L; Chammakhi-jemli C; Cherif A
Presse Med; 2014 Apr; 43(4 Pt 1):478-9. PubMed ID: 24378110
[No Abstract] [Full Text] [Related]
39. Proposals for the management of gastrointestinal stromal tumours of the stomach.
Sujendran V; Fearnhead N; De Pennington N; Warren BF; Maynard ND
Surgeon; 2007 Jun; 5(3):149-53. PubMed ID: 17575668
[TBL] [Abstract][Full Text] [Related]
40. Low MAD2 expression levels associate with reduced progression-free survival in patients with high-grade serous epithelial ovarian cancer.
Furlong F; Fitzpatrick P; O'Toole S; Phelan S; McGrogan B; Maguire A; O'Grady A; Gallagher M; Prencipe M; McGoldrick A; McGettigan P; Brennan D; Sheils O; Martin C; W Kay E; O'Leary J; McCann A
J Pathol; 2012 Apr; 226(5):746-55. PubMed ID: 22069160
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
